Clinical trials
Completed Prediabetic State trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2019 | 4 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shanghai 6th People's Hospital | 2 |
| Société des Produits Nestlé (SPN) | 2 |
| Amway (China) R&D Center | 1 |
| Chinese Academy of Sciences | 1 |
| Chinese Association of Geriatric Research | 1 |
| Eli Lilly and Company | 1 |
| Haisco Pharmaceutical Group Co., Ltd. | 1 |
| Heart Health Research Center | 1 |
| Third Affiliated Hospital, Sun Yat-Sen University | 1 |
| Wellizen Australia | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prediabetic State | 13 |
| Obesity | 2 |
| Diabetes Mellitus | 1 |
| Dyslipidemias | 1 |
| Glucose Intolerance | 1 |
| Glucose Metabolism Disorders | 1 |
| Insulin Resistance | 1 |
| Lipid Metabolism Disorders | 1 |
| Nutrition Disorders | 1 |
| Overweight | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.